Washington, DC (December 18, 2025) – The American Pharmacists Association (APhA) participated in a White House ceremony marking the rescheduling of marijuana as a Schedule III drug. Marijuana’s Schedule I classification imposes strict regulatory requirements that make it difficult for researchers and scientists to obtain it for study. APhA believes that moving marijuana to Schedule III will help accelerate research into its medicinal applications and potentially lead to safer and more effective therapeutic uses.

Washington, DC (December 4, 2025) The American Pharmacists Association (APhA) is deeply disappointed by today’s vote by the CDC’s Advisory Committee on Immunization Practices (ACIP) to remove the universal recommendation for administering the hepatitis B vaccine birth dose for infants born in the United States. This reversal rolls back a highly effective, evidence-based public health measure that has been in place since 1991.

WASHINGTON, DC (December 1, 2025) — The American Pharmacists Association (APhA) and the American Academy of HIV Medicine (AAHIVM) today announced that AAHIVM has formally endorsed the clinical and educational content of APhA’s Pharmacy-Based HIV Prevention Services Certificate Training Program and Microcredential.